Published in Neuropsychopharmacology on May 01, 2001
Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry (2009) 8.74
The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology (2011) 2.15
The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation. J Psychosom Res (2011) 1.63
Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci (2009) 1.58
The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol Psychiatry (2012) 1.41
Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol (2010) 1.38
Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol Psychiatry (2013) 1.26
A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci Biobehav Rev (2009) 1.24
Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology (2010) 1.22
Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression. Curr Opin Investig Drugs (2009) 1.05
Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity. Front Cell Neurosci (2014) 1.01
Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice. J Neuroinflammation (2011) 0.96
Long-term body weight outcomes of antidepressant-environment interactions. Mol Psychiatry (2010) 0.96
Inflammatory Factors Mediate Vulnerability to a Social Stress-Induced Depressive-like Phenotype in Passive Coping Rats. Biol Psychiatry (2014) 0.92
Major depression during interferon-alpha treatment: vulnerability and prevention. Dialogues Clin Neurosci (2009) 0.92
Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? Expert Rev Neurother (2012) 0.89
Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide. J Neuroinflammation (2011) 0.89
Effects of centrally administered etanercept on behavior, microglia, and astrocytes in mice following a peripheral immune challenge. Neuropsychopharmacology (2014) 0.84
Clozapine protects dopaminergic neurons from inflammation-induced damage by inhibiting microglial overactivation. J Neuroimmune Pharmacol (2011) 0.83
Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial. Am J Geriatr Psychiatry (2012) 0.83
Cardiac autonomic imbalance by social stress in rodents: understanding putative biomarkers. Front Psychol (2014) 0.82
Sex-dependent effects of neonatal inflammation on adult inflammatory markers and behavior. Endocrinology (2010) 0.82
Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and HPA axis activation in rats. Psychopharmacology (Berl) (2004) 0.82
Imipramine attenuates neuroinflammatory signaling and reverses stress-induced social avoidance. Brain Behav Immun (2015) 0.82
Somatic drugs for psychiatric diseases: aspirin or simvastatin for depression? Curr Neuropharmacol (2012) 0.81
Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder? Br J Pharmacol (2013) 0.81
Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression. Neuropsychiatr Dis Treat (2008) 0.81
A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue. Front Cell Neurosci (2015) 0.80
Cyclic ADP-Ribose and Heat Regulate Oxytocin Release via CD38 and TRPM2 in the Hypothalamus during Social or Psychological Stress in Mice. Front Neurosci (2016) 0.79
Dynamic microglial modulation of spatial learning and social behavior. Brain Behav Immun (2015) 0.79
Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial. Psychopharmacology (Berl) (2013) 0.79
P2X(7) Receptors in Neurological and Cardiovascular Disorders. Cardiovasc Psychiatry Neurol (2009) 0.78
Genetic biomarkers of depression. Indian J Hum Genet (2012) 0.77
Serotonin as a putative scavenger of hypohalous acid in the brain. Biochim Biophys Acta (2015) 0.76
Antidepressants Impact Connexin 43 Channel Functions in Astrocytes. Front Cell Neurosci (2016) 0.76
Microglia Loss Contributes to the Development of Major Depression Induced by Different Types of Chronic Stresses. Neurochem Res (2017) 0.76
Mitigation of Inflammation-Induced Mood Dysregulation by Long-Chain Omega-3 Fatty Acids. J Am Coll Nutr (2015) 0.75
Deletion of the P2X4 receptor is neuroprotective acutely, but induces a depressive phenotype during recovery from ischemic stroke. Brain Behav Immun (2017) 0.75
The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol (2001) 4.92
Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry (2007) 2.38
Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol (1998) 2.15
Neuroimmune appendicitis. Lancet (1999) 2.05
Social stress induces glucocorticoid resistance in macrophages. Am J Physiol Regul Integr Comp Physiol (2001) 2.03
Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci U S A (1996) 1.94
Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms. Circulation (1981) 1.68
In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia. Antimicrob Agents Chemother (1990) 1.66
Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J Biol Chem (1994) 1.54
Immune cell infiltration and growth-associated protein 43 expression correlate with pain in chronic pancreatitis. Gastroenterology (1997) 1.49
Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide. Ann Neurol (1993) 1.48
Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42
Eicosanoids content in small intestinal mucosa of children with celiac disease. J Pediatr Gastroenterol Nutr (1992) 1.40
Social stress increases the susceptibility to endotoxic shock. J Neuroimmunol (2001) 1.28
Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. II. The peripheral nervous system. Neuroscience (1998) 1.28
Illness, cytokines, and depression. Ann N Y Acad Sci (2000) 1.27
Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. I. Central nervous system. Neuroscience (1998) 1.25
Social disruption, immunity, and susceptibility to viral infection. Role of glucocorticoid insensitivity and NGF. Ann N Y Acad Sci (2000) 1.24
Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation (1984) 1.23
An improved perfusion fixation method for the testis. Anat Rec (1977) 1.22
Cytokines, "depression due to a general medical condition," and antidepressant drugs. Adv Exp Med Biol (1999) 1.20
Fine structural analysis of the synaptic junction of Merkel cell-axon-complexes. J Invest Dermatol (1980) 1.20
Distribution of vasoactive intestinal polypeptide-like immunoreactivity in the mammalian heart. Interrelation with neurotensin- and substance P-like immunoreactive nerves. Cell Tissue Res (1984) 1.20
The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent. J Immunol (2001) 1.14
Severity of neurological signs and degree of inflammatory lesions in the brains of rats with Borna disease correlate with the induction of nitric oxide synthase. J Virol (1993) 1.12
Changes in peptidergic innervation in chronic pancreatitis. Pancreas (1992) 1.12
Complement C1q is dramatically up-regulated in brain microglia in response to transient global cerebral ischemia. J Immunol (2000) 1.11
Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen. J Exp Med (1993) 1.10
Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity. J Virol (2001) 1.09
Neuronal expression of fractalkine in the presence and absence of inflammation. FEBS Lett (1998) 1.03
Limbic pathways and hypothalamic neurotransmitters mediating adrenocortical responses to neural stimuli. Neurosci Biobehav Rev (1995) 1.03
Differential effects of rabies and borna disease viruses on immediate-early- and late-response gene expression in brain tissues. J Virol (1993) 1.02
Properdin, a positive regulator of complement activation, is expressed in human T cell lines and peripheral blood T cells. J Immunol (1993) 1.02
Rescue of HSV-1 neurovirulence is associated with induction of brain interleukin-1 expression, prostaglandin synthesis and neuroendocrine responses. J Neurovirol (1996) 1.02
Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain. J Neurovirol (1995) 1.02
Differential structural requirements for the induction of cell attachment, proliferation and differentiation by the extracellular matrix. Exp Cell Res (1985) 1.01
Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide). Proc Natl Acad Sci U S A (1993) 1.00
The EAE-associated behavioral syndrome: II. Modulation by anti-inflammatory treatments. J Neuroimmunol (2003) 1.00
Regulated expression of proenkephalin A in normal lymphocytes. J Immunol (1989) 0.99
Expression of C1q, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Borna disease or experimental allergic encephalomyelitis. J Neurol Sci (1995) 0.99
Why do young women smoke? V. Role of direct and interactive effects of nicotinic cholinergic receptor gene variation on neurocognitive function. Genes Brain Behav (2007) 0.99
Differential effect of amygdaloid lesions on CRF-41, ACTH and corticosterone responses following neural stimuli. Brain Res (1994) 0.99
Restraint stress-induced thymic involution and cell apoptosis are dependent on endogenous glucocorticoids. J Neuroimmunol (1998) 0.99
The EAE-associated behavioral syndrome: I. Temporal correlation with inflammatory mediators. J Neuroimmunol (2003) 0.98
VIP-immunoreactivity in the skin of various mammals: immunohistochemical, radioimmunological and experimental evidence for a dual localization in cutaneous nerves and merkel cells. Peptides (1984) 0.98
Normal immunosuppressive protein: inhibitory effect on immune response against tumour cells. Immunology (1978) 0.98
Differential expression of mRNA encoding interleukin-12 p35 and p40 subunits in situ. Eur J Immunol (1994) 0.97
The excitatory effects of the amygdala on hypothalamo-pituitary-adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41. Brain Res Bull (1998) 0.97
Suppression of experimental autoimmune encephalomyelitis by cannabinoids. Immunopharmacology (1995) 0.97
Behavioral aspects of experimental autoimmune encephalomyelitis. J Neuroimmunol (2000) 0.97
Peptidergic (neurotensin, VIP, substance P) nerve fibres in the skin. Immunohistochemical evidence of an involvement of neuropeptides in nociception, pruritus and inflammation. Br J Dermatol (1983) 0.96
Distribution of the vesicular acetylcholine transporter (VAChT) in the central and peripheral nervous systems of the rat. J Mol Neurosci (1994) 0.96
Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation. J Clin Invest (1993) 0.95
Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid. J Pharmacol Exp Ther (1997) 0.95
Cytopathologic and neurochemical correlates of progression to motor/cognitive impairment in SIV-infected rhesus monkeys. J Neuropathol Exp Neurol (1994) 0.95
Normal immunosuppressive protein inhibition of human and murine lymphoblastoid cell line proliferation. Eur J Immunol (1979) 0.95
The distinct gene expression of the pro-hormone convertases in the rat heart suggests potential substrates. Cell Tissue Res (1995) 0.95
Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells. Br J Pharmacol (2007) 0.94
Normal immunosuppressive protein purification and quantitative estimation experiments. J Immunol Methods (1979) 0.93
Interleukin-1 inhibits sexual behavior in female but not in male rats. Brain Behav Immun (1995) 0.93
Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur J Pharmacol (1999) 0.93
Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions. Gut (2006) 0.92
Inflammation-induced upregulation of NK1 receptor mRNA in dorsal horn neurones. Neuroreport (1993) 0.92
Cellular and secretory mechanisms related to delayed radiation-induced microvessel dysfunction in the spinal cord of rats. Int J Radiat Oncol Biol Phys (1996) 0.92
Peptidergic innervation (substance P) in the human heart. J Mol Cell Cardiol (1981) 0.92
Differential response to acute and repeated stress in cannabinoid CB1 receptor knockout newborn and adult mice. Behav Pharmacol (2005) 0.92
Localization of xenin-immunoreactive cells in the duodenal mucosa of humans and various mammals. J Histochem Cytochem (2000) 0.92
Repetitive pneumoperitoneum with ozonized oxygen as a preventive in lethal polymicrobial sepsis in rats. Eur Surg Res (2003) 0.91
Accidental injuries are more common in children with attention deficit hyperactivity disorder compared with their non-affected siblings. Child Care Health Dev (2011) 0.91
Intercellular junctions in the full term human placenta. I. Syncytiotrophoblastic layer. Anat Embryol (Berl) (1979) 0.91
[Mathematical modelling of open-wedge tibial osteotomy and correction tables]. Rev Chir Orthop Reparatrice Appar Mot (1992) 0.91
Substance P-immunoreactive nerve fibers in the heart. Neurosci Lett (1980) 0.91
Activation of the adrenocortical axis by surgical stress: involvement of central norepinephrine and interleukin-1. Neuroimmunomodulation (2000) 0.91
Neuronal overexpression of "readthrough" acetylcholinesterase is associated with antisense-suppressible behavioral impairments. Mol Psychiatry (2002) 0.90
Renal nitric oxide production during the early phase of experimental diabetes mellitus. Kidney Int (2000) 0.90
Pan-neuronal expression of chromogranin A in rat nervous system. Peptides (1994) 0.90
Expression of endothelial nitric oxide synthase in the ischemic penumbra: relationship to expression of neuronal nitric oxide synthase and vascular endothelial growth factor. Brain Res (2001) 0.90
Oral administration of the oxidant-scavenger N-acetyl-L-cysteine inhibits acute experimental autoimmune encephalomyelitis. J Neuroimmunol (1994) 0.90
Altered cardiac automaticity and conduction in experimental diabetes mellitus. J Mol Cell Cardiol (1980) 0.90
Glucocorticoid receptor antagonists in the hippocampus modify the negative feedback following neural stimuli. Brain Res (1999) 0.89
The neuro-B cell link of peptidergic innervation in the Bursa Fabricii. Brain Behav Immun (1991) 0.89
Characterization of opioid peptides in guinea-pig heart and skin. Life Sci (1983) 0.89
Immunohistochemical localization of vasoactive intestinal polypeptide (VIP) in Merkel cells of various mammals: evidence for a neuromodulator function of the Merkel cell. J Invest Dermatol (1983) 0.89
Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of 'depression due to multiple sclerosis'. Brain Behav Immun (2002) 0.89